Valproate sodium and Eczema exacerbated - a phase IV clinical study of FDA data

Summary:

Eczema exacerbated is reported as a side effect among people who take Valproate sodium (valproate sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lamictal, and have Schizophrenia.

The phase IV clinical study analyzes which people have Eczema exacerbated when taking Valproate sodium. It is created by eHealthMe based on reports of 23,476 people who have side effects when taking Valproate sodium from the FDA, and is updated regularly.

What is Valproate sodium?

Valproate sodium has active ingredients of valproate sodium. It is often used in epilepsy. eHealthMe is studying from 24,044 Valproate sodium users. Check the latest studies of Valproate sodium.

What is Eczema exacerbated?

Eczema exacerbated is found to be associated with 1,254 drugs and 534 conditions by eHealthMe. Check the latest studies of Eczema exacerbated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

23,476 people reported to have side effects when taking Valproate sodium.
Among them, 41 people (0.17%) have Eczema exacerbated.

Could Valproate sodium cause Eczema exacerbated?

Among these 41 people:

How long have people been on Valproate sodium when they have Eczema exacerbated? *

  • < 1 month: 66.67 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 33.33 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Eczema exacerbated when taking Valproate sodium? *

  • female: 57.5 %
  • male: 42.5 %

What is the age of people who have Eczema exacerbated when taking Valproate sodium? *

  • 0-1: 0.0 %
  • 2-9: 8.7 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 13.04 %
  • 40-49: 30.43 %
  • 50-59: 13.04 %
  • 60+: 34.78 %

What are other drugs people take besides Valproate sodium? *

  1. Folic Acid: 5 people, 12.20%
  2. Lamictal: 5 people, 12.20%
  3. Carbamazepine: 3 people, 7.32%
  4. Risperdal: 3 people, 7.32%
  5. Diazepam: 3 people, 7.32%
  6. Vitamin K: 3 people, 7.32%
  7. Vimpat: 3 people, 7.32%
  8. Invega: 3 people, 7.32%
  9. Tegretol: 3 people, 7.32%
  10. Fluconazole: 2 people, 4.88%

What are other side effects people have besides Eczema exacerbated? *

  1. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 12 people, 29.27%
  2. Rashes (redness): 11 people, 26.83%
  3. Psychomotor Skills Impaired: 10 people, 24.39%
  4. Fever: 9 people, 21.95%
  5. Learning Disorder (the brain's disability to receive, process, store, respond to and communicate information): 9 people, 21.95%
  6. Dysmorphism (difference of body structure that is suggestive of a congenital disorder): 8 people, 19.51%
  7. Speech Disorder Developmental: 8 people, 19.51%
  8. Disturbance In Attention: 8 people, 19.51%
  9. Aggression: 7 people, 17.07%
  10. Knee Deformity (functional disability of knee): 6 people, 14.63%

What are the existing conditions these people have? *

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 12.20%
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 7.32%
  3. Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 2 people, 4.88%
  4. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 4.88%
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 4.88%
  6. Cellulitis (infection under the skin): 2 people, 4.88%
  7. Conjunctivitis (pink eye): 2 people, 4.88%
  8. Constipation: 2 people, 4.88%
  9. Cystitis Haemorrhagic (blood in the urine and painful voiding): 2 people, 4.88%
  10. Diarrhea: 2 people, 4.88%

* Approximation only. Some reports may have incomplete information.

Do you take Valproate sodium and have Eczema exacerbated?

- Check whether Eczema exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Valproate sodium:

Eczema exacerbated treatments and more:

How severe was Eczema exacerbated and when was it recovered:

Expand to all the drugs that have ingredients of valproate sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valproate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eczema exacerbated:

Browse all the conditions that are associated with Eczema exacerbated:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on valproate sodium (the active ingredients of Valproate sodium) and Valproate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: